Physician

Jiyon Jane Choi, MD

According to 2025 Medicare claims, Jiyon Choi, MD (NPI: 1144437567) practices hematology/oncology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is EPIC CARE (NPI: 1780107797; TIN: 821993796) and primary practice location at 94531-8811. Choi is affiliated with the Aledade 147 Hill Physicians MSSP Basic E (ACO ID: A5230), participating under the MSSP model.

Choi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 190,690 HCPCS/CPT codes, and received $3,151,720 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,379 prescription claims across 239 beneficiaries totaling $2,646,342 in drug costs, led by Ibrance (Palbociclib). DME data shows 13 claims. Open Payments data shows 159 records totaling $3,609. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $637,694 to $3,151,720. Similarly, Part D prescription costs have moved sharply higher in recent years, from $571,912 to $2,646,342. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	222	44,772	$637,694
2016	227	86,680	$1,011,900
2017	314	83,648	$1,130,177
2018	349	81,945	$1,381,848
2019	334	103,108	$1,724,612
2020	367	123,669	$1,875,718
2021	409	109,130	$2,293,002
2022	497	129,248	$2,545,713
2023	521	130,468	$2,861,780
2024	517	190,690	$3,151,720

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	96	489	$571,912
2016	94	488	$426,066
2017	121	833	$875,013
2018	140	946	$1,224,088
2019	136	877	$1,193,532
2020	133	956	$1,286,043
2021	147	1,016	$1,332,245
2022	182	1,025	$1,776,402
2023	202	1,050	$2,803,718
2024	239	1,379	$2,646,342

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	33	$1,950
2023	N/R	16	$6,205
2024	N/R	13	$594

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	124	327	$118
99442	Telephone medical discussion with physician, 11-20 minutes	170	373	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	234	$75
36415	Insertion of needle into vein for collection of blood sample	168	721	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	155	586	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	51	1,428	$767,869
Tagrisso	Osimertinib Mesylate	30	900	$470,287
Calquence	Acalabrutinib Maleate	20	600	$307,418
Lenalidomide	Lenalidomide	15	420	$228,736
Imbruvica	Ibrutinib	14	392	$222,080

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$594

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	159	$3,609	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jiyon Jane Choi, MD?

Tedicare shows public-source Medicare data for Jiyon Jane Choi, MD (NPI 1144437567), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jiyon Jane Choi, MD have ACO affiliation data?

Jiyon Jane Choi, MD is shown with ACO affiliation data for Aledade 147 Hill Physicians MSSP Basic E (MSSP, ACO ID A5230).

What billing organization is linked to Jiyon Jane Choi, MD?

Jiyon Jane Choi, MD is linked to EPIC CARE (billing NPI 1780107797) in the available physician profile data.

Does Jiyon Jane Choi, MD have Open Payments data?

Jiyon Jane Choi, MD has 159 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.